These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 31041810

  • 41. Secreted protein acidic and rich in cysteine gene variants: Impact on susceptibility and survival of hepatocellular carcinoma patients.
    Darweesh SK, Abd Alziz RA, Omar H, Sabry D, Fathy W.
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1424-1431. PubMed ID: 30422339
    [Abstract] [Full Text] [Related]

  • 42. miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma.
    Zhang X, Jiang P, Shuai L, Chen K, Li Z, Zhang Y, Jiang Y, Li X.
    J Exp Clin Cancer Res; 2016 Nov 11; 35(1):176. PubMed ID: 27835990
    [Abstract] [Full Text] [Related]

  • 43. AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.
    Chen C, Song G, Xiang J, Zhang H, Zhao S, Zhan Y.
    Biochem Biophys Res Commun; 2017 Apr 29; 486(2):514-520. PubMed ID: 28322787
    [Abstract] [Full Text] [Related]

  • 44. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
    Karkampouna S, van der Helm D, Gray PC, Chen L, Klima I, Grosjean J, Burgmans MC, Farina-Sarasqueta A, Snaar-Jagalska EB, Stroka DM, Terracciano L, van Hoek B, Schaapherder AF, Osanto S, Thalmann GN, Verspaget HW, Coenraad MJ, Kruithof-de Julio M.
    J Pathol; 2018 Jul 29; 245(3):297-310. PubMed ID: 29604056
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Overexpression of OCT4 contributes to progression of hepatocellular carcinoma.
    Xu G, Qi F, Zhang J, Xu J, Shi T, Miao Y.
    Tumour Biol; 2016 Apr 29; 37(4):4649-54. PubMed ID: 26508029
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.
    Ding W, You H, Dang H, LeBlanc F, Galicia V, Lu SC, Stiles B, Rountree CB.
    Hepatology; 2010 Sep 29; 52(3):945-53. PubMed ID: 20564331
    [Abstract] [Full Text] [Related]

  • 51. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
    Sun L, Li PB, Yao YF, Xiu AY, Peng Z, Bai YH, Gao YJ.
    World J Gastroenterol; 2018 Mar 14; 24(10):1120-1133. PubMed ID: 29563756
    [Abstract] [Full Text] [Related]

  • 52. Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway.
    Kong X, Peng H, Liu P, Fu X, Wang N, Zhang D.
    Cancer Sci; 2023 Jun 14; 114(6):2265-2276. PubMed ID: 36751987
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, E F, Lv G, Zou C, Wang C, Si L, Zou C, Li Q, Gao X.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):46. PubMed ID: 29506532
    [Abstract] [Full Text] [Related]

  • 55. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
    Chen J, Zhu H, Liu Q, Ning D, Zhang Z, Zhang L, Mo J, Du P, Liu X, Song S, Fan Y, Liang H, Liu J, Zhang B, Chen X.
    J Exp Clin Cancer Res; 2019 Jun 22; 38(1):273. PubMed ID: 31228948
    [Abstract] [Full Text] [Related]

  • 56. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells.
    Liu YM, Li XF, Liu H, Wu XL.
    Oncol Rep; 2015 Dec 22; 34(6):2977-86. PubMed ID: 26370320
    [Abstract] [Full Text] [Related]

  • 57. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition.
    Lv G, Tan Y, Lv H, Fang T, Wang C, Li T, Yu Y, Hu C, Wen W, Wang H, Yang W.
    Sci China Life Sci; 2017 Nov 22; 60(11):1203-1213. PubMed ID: 28812296
    [Abstract] [Full Text] [Related]

  • 58. Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.
    Tan HW, Leung CO, Chan KK, Ho DW, Leung MS, Wong CM, Ng IO, Lo RC.
    Int J Cancer; 2019 Oct 01; 145(7):1860-1873. PubMed ID: 30834518
    [Abstract] [Full Text] [Related]

  • 59. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z, Qu L, Deng B, Sun X, Wu S, Liao J, Fan J, Peng Z.
    Sci Rep; 2016 Sep 15; 6():33205. PubMed ID: 27628214
    [Abstract] [Full Text] [Related]

  • 60. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.
    Wang J, Yang X, Ruan B, Dai B, Gao Y, Duan J, Qu S, Tao K, Dou K, Li H.
    Tumour Biol; 2015 Apr 15; 36(4):2447-56. PubMed ID: 25412960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.